Revolutionary blood test monitors gene expression dynamics in the brain

The brain is the most protected organ in the body, sheathed in a complex and nearly impenetrable barrier of specialized blood vessels.

FDA OKs First Pill for Postpartum Depression

The FDA approved zuranolone (Zurzuvae) as the first oral treatment for postpartum depression, the agency announced late on Friday. Until now, brexanolone (Zulresso) has been

August 6, 2023

What to know about Dr. Oz, Trump’s pick to head CMS

Good morning. What a newsy week. I’m Isabella Cueto, a chronic disease reporter at STAT, and so it’s my duty to say: Pause. Deep breath.

November 20, 2024

FDA warns industry of ‘fraudulent’ third-party data in device applications

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Food and Drug Administration

February 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.